Muscle Recovery
Peptides researched for muscle repair, hypertrophy support, and post-exercise recovery. Each compound links to its full dosing protocol.
Research Use Only. All dosing information is for educational purposes. Consult a licensed healthcare provider before making health decisions.
BPC-157
Body Protection Compound-157 stimulates angiogenesis and accelerates tissue repair. Widely researched for muscle, tendon, and ligament healing with potent anti-inflammatory properties.
Route: Subcutaneous injection
Reconstitution: 3.0 mL bacteriostatic water → 1.67 mg/mL concentration
Dose Range: 200–600 mcg once daily (gradual titration)
Cycle: 8–12 weeks; optional extension to 16 weeks
Schedule: Weeks 1–2: 200 mcg → Weeks 3–4: 400 mcg → Weeks 5–8+: 600 mcg → Weeks 1–2: 200 mcg
- Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing — Cell Tissue Res, 2019
- BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing — Curr Pharm Des, 2018
- Rotator cuff biology and biomechanics: a review of normal and pathological conditions — Curr Rheumatol Rep, 2015
TB-500
Thymosin Beta-4 fragment that promotes cell migration, blood vessel formation, and tissue repair. Researched for muscle flexibility, healing, and reducing inflammation post-injury.
Route: Subcutaneous injection
Reconstitution: 3.0 mL bacteriostatic water → ~1.67 mg/mL concentration
Dose Range: 500–1000 mcg once daily (gradual titration recommended)
Cycle: 8–12 weeks; optional extension to 16 weeks
Schedule: Weeks 1–2: 500 mcg 30 → Weeks 3–4: 600 mcg 36 → Weeks 5–8: 750 mcg 45 → Weeks 9–12: 1000 mcg 60
- CGRP sensory neurons promote tissue healing via neutrophils and macrophages — Nature, 2024
- Burn-induced hypermetabolism and skeletal muscle dysfunction — Am J Physiol Cell Physiol, 2021
- Muscle Healing in Sports Injuries: MRI Findings and Proposed Classification Based on a Single Institutional Experience and Clinical Observation — Radiographics, 2024
IGF-1 LR3
Long-acting insulin-like growth factor that promotes muscle cell proliferation and differentiation. Key mediator of growth hormone effects on muscle tissue.
Route: Subcutaneous injection
Reconstitution: 3.0 mL bacteriostatic water → ~0.333 mg/mL concentration
Dose Range: 20–50 mcg once daily subcutaneously (gradual titration recommended)
Cycle: 8 weeks standard; 12-week protocols exist but may show diminished returns beyond Week 6–8
Schedule: Weeks 1–2: 20 mcg → Weeks 3–4: 40 mcg → Weeks 5–8: 50 mcg
- An Evidence-Based Narrative Review of Mechanisms of Resistance Exercise-Induced Human Skeletal Muscle Hypertrophy — Med Sci Sports Exerc, 2022
- Skeletal muscle hypertrophy rewires glucose metabolism: An experimental investigation and systematic review — J Cachexia Sarcopenia Muscle, 2024
- Coronary vascular growth matches IGF-1-stimulated cardiac growth in fetal sheep — FASEB J, 2020
CJC No DAC
Modified GRF (1-29) that stimulates pulsatile growth hormone release. Supports recovery by amplifying natural GH secretion patterns important for muscle repair.
Route: Subcutaneous injection
Reconstitution: 3.0 mL bacteriostatic water → ~1.67 mg/mL concentration
Dose Range: 100–300 mcg once daily (gradual titration)
Cycle: 8–12 weeks; optional extension to 16 weeks
Schedule: Weeks 1–2: 100 mcg 6 → Weeks 3–4: 150 mcg 9 → Weeks 5–6: 200 mcg 12 → Weeks 7–12: 250–300 mcg 15–18
- Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions — Subst Use Misuse, 2016
- Glycine-modified growth hormone secretagogues identified in seized doping material — Drug Test Anal, 2019
- Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist — Endocrinology, 1985
Ipamorelin
Selective growth hormone secretagogue that stimulates GH release without significantly affecting cortisol or prolactin. Clean GH pulse for recovery support.
Route: Subcutaneous injection
Reconstitution: 3.0 mL bacteriostatic water → ~1.67 mg/mL concentration
Dose Range: 100–250 mcg once daily (gradual titration recommended)
Cycle: 8–12 weeks; optional extension to 16 weeks, followed by 2–4 week off-cycle
Schedule: Weeks 1–2: 100 mcg 6 → Weeks 3–4: 150 mcg 9 → Weeks 5–8: 200 mcg 12 → Weeks 9–12: 250 mcg 15
- The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats — Growth Horm IGF Res, 2001
- A shared central thalamus mechanism underlying diverse recoveries in disorders of consciousness — Nat Commun, 2025
- Recovery of marine animal populations and ecosystems — Trends Ecol Evol, 2011
MK-677
Oral growth hormone secretagogue (ibutamoren) that increases GH and IGF-1 levels. Researched for muscle mass preservation, sleep quality, and recovery.
Route: Oral
- Body composition techniques — Indian J Med Res, 2018
- Body composition by DXA — Bone, 2017
- LGD-4033 and MK-677 use impacts body composition, circulating biomarkers, and skeletal muscle androgenic hormone and receptor content: A case report — Exp Physiol, 2022
All information is intended strictly for educational and research purposes. Not medical advice. Consult a licensed healthcare provider before making any health decisions.